AGLITTI, Andrea
AGLITTI, Andrea
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study
2021-01-01 Masarone, Mario; Vaccaro, Emilia; Sciorio, Roberta; Torre, Pietro; Della Vecchia, Antonio; Aglitti, Andrea; Caliulo, Rita; Borrelli, Anna; Persico, Marcello
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
2019-01-01 Lawitz, E.; Flisiak, R.; Abunimeh, M.; Sise, M. E.; Park, J. Y.; Kaskas, M.; Bruchfeld, A.; Worns, M. -A.; Aglitti, A.; Zamor, P. J.; Xue, Z.; Schnell, G.; Jalundhwala, Y. J.; Porcalla, A.; Mensa, F. J.; Persico, M.
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma
2018-01-01 Persico, Marcello; Aglitti, Andrea; Caruso, Rosa; De Renzo, Amalia; Selleri, Carmine; Califano, Catello; Abenavoli, Ludovico; Federico, Alessandro; Masarone, Mario
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy
2019-01-01 Persico, Marcello; Masarone, Mario; Aglitti, Andrea; Armenante, Ciro; Giordano, Aniello; Guardiola, Angela; Raimondi, Gabriella; Contaldi, Carlo; Nigro, Carmine; Marena, Giustina; De Luna, Antonio
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program
2020-01-01 Masarone, M.; Caruso, R.; Aglitti, A.; Izzo, C.; De Matteis, G.; Attianese, M. R.; Pagano, A. M.; Persico, M.
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma
2018-01-01 Persico, Marcello; Aglitti, Andrea; Aghemo, Alessio; Rendina, Maria; Lleo, Ana; Ciancio, Alessia; Di Marco, Vito; Lampertico, Pietro; Brunetto Maurizia, Rossano; Zuin, Massimo; Andreone, Pietro; Villa, Erica; Troshina, G; Calvaruso, Vincenza; Degasperi, E6; Coco, Barbara; Giorgini, A6; Conti, F8; Di Leo, A3; Marzi, L9; Boccaccio, Vincenzo; Bollani, Stefano; Maisonneuve, Patrick; Bruno, Savino.
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
2017-01-01 Masarone, Mario; Rosato, Valerio; Aglitti, Andrea; Bucci, Tommaso; Caruso, Rosa; Salvatore, Teresa; Sasso, Ferdinando Carlo; Tripodi, MARIE FRANCOISE; Persico, Marcello
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome
2019-01-01 Rosato, V.; Masarone, M.; Dallio, M.; Federico, A.; Aglitti, A.; Persico, M.
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
2019-01-01 Lleo, A.; Aglitti, A.; Aghemo, A.; Maisonneuve, P.; Bruno, S.; Persico, M.; Rendina, M.; Ciancio, A.; Lampertico, P.; Brunetto, M. R.; Di Marco, V.; Zuin, M.; Andreone, P.; Villa, E.; Troshina, G.; Degasperi, E.; Coco, B.; Calvaruso, V.; Giorgini, A. M.; Conti, F.; Di Leo, A.; Marzi, L.; Boccaccio, V.; Bollani, S.; Colombo, M.
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease
2019-01-01 Aglitti, A.; Caruso, R.; Calvanese, G.; Di Siervi, P.; Tripodi, M. F.; Masarone, M.; Persico, M.
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study
2019-01-01 Persico, Marcello; Aglitti, Andrea; Milella, Michele; Coppola, Carmine; Messina, Vincenzo; Claar, Ernesto; Gentile, Ivan; Sogari, Fernando; Pierri, Paola; Surace, Lorenzo Antonio; Morisco, Filomena; Tundo, Paolo; Brancaccio, Giuseppina; Serviddio, Gaetano; Gatti, Pietro; Termite, Antonio Patrizio; Di Costanzo, Giovan Giuseppe; Caroleo, Benedetto; Cozzolongo, Raffaele; Coppola, Nicola; Longo, Annamaria; Fontanella, Luca; Federico, Alessandro; Rosato, Valerio; Terrenato, Irene; Masarone, Mario
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease
2019-01-01 Persico, Marcello; Aglitti, Andrea; Caruso, Rosa; Calvanese, Gemma; Di Siervi, Pasqualina; Masarone, Mario
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
2018-01-01 Masarone, Mario; Rosato, Valerio; Dallio, Marcello; Gravina, Antonietta Gerarda; Aglitti, Andrea; Loguercio, Carmelina; Federico, Alessandro; Persico, Marcello
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis
2017-01-01 Persico, Marcello; Rosato, Valerio; Aglitti, Andrea; Precone, Davide; Corrado, Mariano; DE LUNA, Antonio; Morisco, Filomena; Camera, Silvia; Federico, Alessandro; Dallio, Marcello; Claar, Ernesto; Caporaso, Nicola; Masarone, Mario
The diagnostic conundrum in non-alcoholic fatty liver disease
2020-01-01 Rosato, Valerio; Masarone, Mario; Aglitti, Andrea; Persico, Marcello
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis
2021-01-01 Masarone, Mario; Troisi, Jacopo; Aglitti, Andrea; Torre, Pietro; Colucci, Angelo; Dallio, Marcello; Federico, Alessandro; Balsano, Clara; Persico, Marcello
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets
2018-01-01 Gravina, Antonietta Gerarda; Dallio, Marcello; Masarone, Mario; Rosato, Valerio; Aglitti, Andrea; Persico, Marcello; Loguercio, Carmelina; Federico, Alessandro
Viral hepatitis: Milestones, unresolved issues, and future goals
2021-01-01 Torre, P.; Aglitti, A.; Masarone, M.; Persico, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study | 1-gen-2021 | Masarone, Mario; Vaccaro, Emilia; Sciorio, Roberta; Torre, Pietro; Della Vecchia, Antonio; Aglitti, Andrea; Caliulo, Rita; Borrelli, Anna; Persico, Marcello | |
| Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection | 1-gen-2019 | Lawitz, E.; Flisiak, R.; Abunimeh, M.; Sise, M. E.; Park, J. Y.; Kaskas, M.; Bruchfeld, A.; Worns, M. -A.; Aglitti, A.; Zamor, P. J.; Xue, Z.; Schnell, G.; Jalundhwala, Y. J.; Porcalla, A.; Mensa, F. J.; Persico, M. | |
| Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma | 1-gen-2018 | Persico, Marcello; Aglitti, Andrea; Caruso, Rosa; De Renzo, Amalia; Selleri, Carmine; Califano, Catello; Abenavoli, Ludovico; Federico, Alessandro; Masarone, Mario | |
| HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy | 1-gen-2019 | Persico, Marcello; Masarone, Mario; Aglitti, Andrea; Armenante, Ciro; Giordano, Aniello; Guardiola, Angela; Raimondi, Gabriella; Contaldi, Carlo; Nigro, Carmine; Marena, Giustina; De Luna, Antonio | |
| Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program | 1-gen-2020 | Masarone, M.; Caruso, R.; Aglitti, A.; Izzo, C.; De Matteis, G.; Attianese, M. R.; Pagano, A. M.; Persico, M. | |
| High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma | 1-gen-2018 | Persico, Marcello; Aglitti, Andrea; Aghemo, Alessio; Rendina, Maria; Lleo, Ana; Ciancio, Alessia; Di Marco, Vito; Lampertico, Pietro; Brunetto Maurizia, Rossano; Zuin, Massimo; Andreone, Pietro; Villa, Erica; Troshina, G; Calvaruso, Vincenza; Degasperi, E6; Coco, Barbara; Giorgini, A6; Conti, F8; Di Leo, A3; Marzi, L9; Boccaccio, Vincenzo; Bollani, Stefano; Maisonneuve, Patrick; Bruno, Savino. | |
| Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage | 1-gen-2017 | Masarone, Mario; Rosato, Valerio; Aglitti, Andrea; Bucci, Tommaso; Caruso, Rosa; Salvatore, Teresa; Sasso, Ferdinando Carlo; Tripodi, MARIE FRANCOISE; Persico, Marcello | |
| NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome | 1-gen-2019 | Rosato, V.; Masarone, M.; Dallio, M.; Federico, A.; Aglitti, A.; Persico, M. | |
| Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals | 1-gen-2019 | Lleo, A.; Aglitti, A.; Aghemo, A.; Maisonneuve, P.; Bruno, S.; Persico, M.; Rendina, M.; Ciancio, A.; Lampertico, P.; Brunetto, M. R.; Di Marco, V.; Zuin, M.; Andreone, P.; Villa, E.; Troshina, G.; Degasperi, E.; Coco, B.; Calvaruso, V.; Giorgini, A. M.; Conti, F.; Di Leo, A.; Marzi, L.; Boccaccio, V.; Bollani, S.; Colombo, M. | |
| Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease | 1-gen-2019 | Aglitti, A.; Caruso, R.; Calvanese, G.; Di Siervi, P.; Tripodi, M. F.; Masarone, M.; Persico, M. | |
| Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study | 1-gen-2019 | Persico, Marcello; Aglitti, Andrea; Milella, Michele; Coppola, Carmine; Messina, Vincenzo; Claar, Ernesto; Gentile, Ivan; Sogari, Fernando; Pierri, Paola; Surace, Lorenzo Antonio; Morisco, Filomena; Tundo, Paolo; Brancaccio, Giuseppina; Serviddio, Gaetano; Gatti, Pietro; Termite, Antonio Patrizio; Di Costanzo, Giovan Giuseppe; Caroleo, Benedetto; Cozzolongo, Raffaele; Coppola, Nicola; Longo, Annamaria; Fontanella, Luca; Federico, Alessandro; Rosato, Valerio; Terrenato, Irene; Masarone, Mario | |
| Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease | 1-gen-2019 | Persico, Marcello; Aglitti, Andrea; Caruso, Rosa; Calvanese, Gemma; Di Siervi, Pasqualina; Masarone, Mario | |
| Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease | 1-gen-2018 | Masarone, Mario; Rosato, Valerio; Dallio, Marcello; Gravina, Antonietta Gerarda; Aglitti, Andrea; Loguercio, Carmelina; Federico, Alessandro; Persico, Marcello | |
| Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis | 1-gen-2017 | Persico, Marcello; Rosato, Valerio; Aglitti, Andrea; Precone, Davide; Corrado, Mariano; DE LUNA, Antonio; Morisco, Filomena; Camera, Silvia; Federico, Alessandro; Dallio, Marcello; Claar, Ernesto; Caporaso, Nicola; Masarone, Mario | |
| The diagnostic conundrum in non-alcoholic fatty liver disease | 1-gen-2020 | Rosato, Valerio; Masarone, Mario; Aglitti, Andrea; Persico, Marcello | |
| Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis | 1-gen-2021 | Masarone, Mario; Troisi, Jacopo; Aglitti, Andrea; Torre, Pietro; Colucci, Angelo; Dallio, Marcello; Federico, Alessandro; Balsano, Clara; Persico, Marcello | |
| Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets | 1-gen-2018 | Gravina, Antonietta Gerarda; Dallio, Marcello; Masarone, Mario; Rosato, Valerio; Aglitti, Andrea; Persico, Marcello; Loguercio, Carmelina; Federico, Alessandro | |
| Viral hepatitis: Milestones, unresolved issues, and future goals | 1-gen-2021 | Torre, P.; Aglitti, A.; Masarone, M.; Persico, M. |